Abstract Context Approximately 0.4–1.3% of the worldwide population is transgender.
Although the exact prevalence is unknown, there is an increase in open identification as …

Abstract Purpose of Review To systematically review the evidence on prostate cancer (PCa)
in transgender women (TGW). Recent Findings A total of 25 studies were included. Fourteen …

Objective To review of the existing literature, current guidelines and standard of practice
related to prostate cancer in transgender women, as the transgender population share many …

Introduction Factors influencing patient behavior regarding risk of prostate cancer (PCa) and
outcomes of PCa treatments are poorly understood. Similarly, how PCa treatments affect …

Abstract Transgender individuals represent 0.55% of the US population, equivalent to 1.4
million transgender adults. In transgender women, feminisation can include a number of …

Introduction As the transgender patient population continues to increase, urologists and
other providers who treat genitourinary malignancies will increasingly encounter cases of …

Abstract Male-to-female (MtF) transgender individuals are at risk for prostate cancer,
although guidelines for screening and management in this population are not well …

Objective To critically analyze the available evidence regarding the incidence,
etiopathogenesis, and management of prostate cancer (CaP) in transgender women. In …

Over the last 50 years cancer mortality has decreased, the biggest contributor to this
decrease has been the widespread adoption of cancer screening protocols. These …

Methods| After Durham VA institutional review board approval with a waiver of informed
consent, VA records for all adults with an International Classification of Diseases code for …